Global Hematology Analyzers Market Overview:
Due to upsurging instances of blood circulation disorders as well as growing blood donating population will lead to drive global hematology analyzers market. These analyzers are used to tests and inspect blood samples. It is also used in the medical field to analyze complete blood counts, white blood cell counts, coagulation tests, and reticulocyte analysis. Hematology analyzers can be developed for both humans and animals which has number of applications in veterinarian hospitals, research labs and zoos. Different hematology analyzers possess varying properties. For instance; open sampling testing & closed vial testing. Many analyzers enable users to select efficient and effective hematology analyzers.
As per latest study released by AMA Research, the Global Hematology Analyzers market is expected to see growth rate of 8.34% and may see market size of USD5.34 Million by 2030.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2018-2023 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Rapid Technological Advancements in Generating New Reagents and Catalysts for Effective Treatments and Increasing Adoption of Automated Hematology Analyzers
Market Growth Drivers:
Growing Instances of Blood Circulation Disorders and Blood Donating Population and Incorporation of Hematology Analyzing Technique with Flow Cytometry
Challenges:
Skilled Workforce Required for Hematology Analyzers Development and Stringent and Volatile Government Regulations and Trade Policies
Restraints:
Lack of Adoption of Hematology Analyzers in Underdeveloped Regions and Comparatively Expensive Treatment as well as Availability of Substitutes
Opportunities:
Market Penetration of Hematology Analyzers in Emerging Economies and Introduction to Microfluidics Technology for Improved Hematology Analysis
Competitive Landscape:
Key players are adopting numerous strategies to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnerships to adopt certain technologies, and acquiring small players to finish the competition in the future. As well as investing money in the R&D sector to make technical upgrades to the product.
Some of the key players profiled in the report are Sysmex (Japan), Danaher (United States), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (United States), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (United States), BioSystems (Spain) and Diatron (Hungary). The Players having a strong hold in the market are Sysmex, Danaher, Nihon Kohden, Siemens, and Abbott Laboratories. Additionally, following companies can also be profiled that are part of our coverage like Drew Scientific (United States), EKF Diagnostics (United Kingdom), Mindray (China), Ortho Clinical Diagnostics (United States) and Roche (Switzerland). Analyst at AMA Research see United States and European Players to retain maximum share of Global Hematology Analyzers market by 2030. Considering Market by Price, the sub-segment i.e. High will boost the Hematology Analyzers market.
Latest Market Insights:
On February 14, 2023, Siemens Health announced a strategic partnership with Boule Diagnostics, a Chinese in-vitro diagnostics (IVD) company, to co-develop and commercialize new hematology analyzers for the Chinese market.
On October 26, 2023, Sysmex Corporation launched its new XN-3000 hematology analyzer in the US market. This new analyzer is designed for high-volume laboratories and features faster turnaround times and improved automation.
What Can be Explored with the Hematology Analyzers Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Hematology Analyzers Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Hematology Analyzers
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Hematology Analyzers market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Hematology Analyzers market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Hematology Analyzer Manufacturers, Hematology Analyzer Distributors and Traders, Healthcare Industry Associations, Hospitals and Clinics, Government Agencies, Research and Development Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.